A CXCL1 paracrine network links cancer chemoresistance and metastasis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cell

• Publication date

  2012-07-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cell.2012.04.042PMID 22770218PMCID PMC3528019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

  2012cited by this paper
• Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling

  2011cited by this paper
• Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids.

  2011cited by this paper
• S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression

  2011cited by this paper
• Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.

  2011cited by this paper
• Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer.

  2011cited by this paper
• Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

  2011influential reference
• Mutant BRAF melanomas--dependence and resistance.

  2011cited by this paper
• DNA damage-mediated induction of a chemoresistant niche.

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Therapeutic options for metastatic breast cancer

  2009cited by this paper
• Genes that mediate breast cancer metastasis to the brain

  2009cited by this paper
• CXCR2 antagonists for the treatment of pulmonary disease.

  2009cited by this paper
• CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.

  2009cited by this paper
• Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy

  2009cited by this paper
• Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1

  2009cited by this paper
• Latent bone metastasis in breast cancer tied to Src-dependent survival signals.

  2009cited by this paper
• Tumor self-seeding by circulating cancer cells.

  2009influential reference
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer.

  2009cited by this paper
• Modes of resistance to anti-angiogenic therapy

  2008cited by this paper
• Endogenous human microRNAs that suppress breast cancer metastasis

  2008cited by this paper
• Fascin Expression in Human Embryonic, Fetal, and Normal Adult Tissue

  2008cited by this paper
• Metastatic breast cancer: the treatment challenge.

  2008cited by this paper
• Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1

  2008cited by this paper
• The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase

  2008cited by this paper
• Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor

  2008cited by this paper
• The role of myeloid cells in the promotion of tumour angiogenesis

  2008cited by this paper
• Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.

  2008cited by this paper
• Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

  2007cited by this paper
• Overview of resistance to systemic therapy in patients with breast cancer.

  2007influential reference
• Altered Immune Function during Long-Term Host-Tumor Interactions Can Be Modulated to Retard Autochthonous Neoplastic Growth1

  2007cited by this paper
• Lung metastasis genes couple breast tumor size and metastatic spread

  2007cited by this paper
• Mediators of vascular remodelling co-opted for sequential steps in lung metastasis

  2007cited by this paper
• Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells

  2007cited by this paper
• CXC chemokines located in the 4q21 region are up-regulated in breast cancer.

  2007cited by this paper
• S100A8 and S100A9 in inflammation and cancer.

  2006influential reference
• Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

  2006cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Genes that mediate breast cancer metastasis to lung

  2005influential reference
• Cancer and the chemokine network

  2004cited by this paper
• Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.

  2004cited by this paper
• Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays.

  2003cited by this paper
• Myeloid Cell Function in MRP-14 (S100A9) Null Mice

  2003influential reference
• Fine tuning the transcriptional regulation of the CXCL1 chemokine.

  2003cited by this paper
• Mapping of genomic clones by fluorescence in situ hybridization.

  2001cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Metastasis of cancer: a conceptual history from antiquity to the 1990s.

  2000influential reference
• A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage.

  1993influential reference
• Breast tumor cell lines from pleural effusions.

  1974cited by this paper

• Prominent protumoral cellular compartments of the tumor microenvironment in triple-negative breast cancer

  2026cites this paper
• Spatiotemporal dynamics of tumor-associated neutrophils: bridging the gap between cancer progression and immunotherapy

  2026cites this paper
• Engineering perfusion to meet tumor biology: are vascularized tumor-on-a-chip models ready to drive therapy innovation?

  2026cites this paper
• Turning Foe into Friend: Bridging Neutrophil Biological Characteristics and Neutrophil‐Based Oncolytic Nanotherapeutics

  2026cites this paper
• Tumor-Associated Macrophage-Derived CXCL1 Promotes Endometrial Cancer Progression Through the CXCR2/NF-κB Pathway.

  2026cites this paper
• High-CD14-expressing urothelial cancer cells foster a neutrophil-rich tumor microenvironment that increases the risk of radiation-promoted distant metastasis

  2026cites this paper
• A Novel Prognostic Signature Composed of Autophagy and Liver Metastasis in Colorectal Cancer: Comprehensive Analysis of Bulk and Single-Cell Transcriptomic Data

  2026cites this paper
• Direct delivery of assay reagents to extracellular vesicles in liquid biopsies for biomarker analysis.

  2026cites this paper
• Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer

  2026cites this paper
• Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment.

  2026cites this paper
• Mechanisms of therapy resistance in the tumor microenvironment: Insights from antibody array-based cytokine profiling.

  2026cites this paper
• Unveiling the Link to ABC Proteins and Epithelial-Mesenchymal Transition in Cancer

  2025cites this paper
• Genetic determinants of inflammatory cytokines and their causal relationship with inflammatory disorders of breast: a two-sample Mendelian randomization study

  2025cites this paper
• Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer

  2025cites this paper
• Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer

  2025cites this paper
• THSD4 promotes hair growth by facilitating dermal papilla and hair matrix interactions

  2025cites this paper
• Potential biological roles of exosomal non‐coding RNAs in breast cancer

  2025cites this paper
• Prevalence and prognostic significance of interstitial lung abnormalities in lung cancer: A meta-analysis.

  2025cites this paper
• The role of the CXC chemokine family in endometriosis research and its therapeutic potential

  2025cites this paper
• The molecular and immune microenvironmental landscape of brain metastases: Implications for novel treatment options

  2025cites this paper
• Circulating CD3 + CD8 + T Lymphocytes as Indicators of Disease Status in Patients With Early Breast Cancer

  2025cites this paper
• TGFβ1–TNFα-regulated secretion of neutrophil chemokines is independent of epithelial–mesenchymal transition in breast tumor cells

  2025cites this paper
• Hypoxic breast cancer cell-derived exosomal miR-143-3p targets RICTOR to regulate M2 macrophage polarization, thereby modulating cancer cell invasiveness

  2025cites this paper
• A Broad-Spectrum Chemokine Inhibitor Drives M2 Macrophage Polarization Through Modulation of the Myometrial Secretome

  2025cites this paper
• ODSEI Chip: An Open 3D Microfluidic Platform for Studying Tumor Spheroid‐Endothelial Interactions

  2025cites this paper
• Fractionated radiotherapy initiated at the early stage of bone metastasis is effective to prolong survival in mouse model

  2025cites this paper
• Pharmacokinetics, side effects, dosage forms, drug interactions of curcu-mine

  2025cites this paper
• Nutrients Lowering Obesity-Linked Chemokines Blamable for Metastasis

  2025cites this paper
• Elucidating the immunomodulatory roles and mechanisms of CUL4B in the immune system: a comprehensive review

  2025cites this paper
• Identification of characteristic genes in cutaneous squamous cell carcinoma based on weighted gene co-expression network analysis

  2025cites this paper
• Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer

  2025cites this paper
• CCCdb: a comprehensive manually curated database for cell–cell communication in human and mouse

  2025cites this paper
• Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells.

  2025cites this paper
• A new concept for oncogenic analysis of tumor microenvironment and chemokines and non-coding RNAs in breast cancer

  2025cites this paper
• Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated Immunosuppressive Tumor Microenvironment

  2025cites this paper
• Application of in vitro and in vivo cancer models to study the impact of the tumor immune microenvironment on anticancer therapy.

  2025cites this paper
• Neutrophil-Related Genes Predict Prognosis and Contribute to Immunosuppression in Acute Myeloid Leukemia

  2025cites this paper
• The Critical Role of Homing in TIL Therapy Success: From Biology to Clinical Application.

  2025cites this paper
• Insights on the role of the chemokine CCL8 in pathology.

  2025cites this paper
• Loss of HDAC-Mediated Repression and Gain of NF-κB Activation Underlie Cytokine Induction in ARID1A- and PIK3CA-Mutation-Driven Ovarian Cancer.

  2025influential citation
• Elevated CXCL1 expression contributes to the development of pediatric Crohn's disease and serves as a diagnostic marker: A reanalysis based on the integrative bioinformatics.

  2025cites this paper
• TLR9 Downregulation in Breast Cancer: Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence

  2025cites this paper
• Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy

  2025cites this paper
• The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target

  2025cites this paper
• ANG secretion predisposes endothelial cells toward angiogenesis in FIN56-induced ferroptotic hepatocellular carcinoma via the BMP6/ID1 signaling pathway.

  2025cites this paper
• Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer

  2025cites this paper
• S100A8/A9 innate immune signaling as a distinct mechanism driving progression of smoking-related breast cancers

  2025cites this paper
• C-X-C motif chemokine ligand 1 derived from oral squamous cell carcinoma promotes cancer-associated fibroblast differentiation and tumor growth

  2025cites this paper
• Docetaxel Administration via Novel Hierarchical Nanoparticle Reduces Proinflammatory Cytokine Levels in Prostate Cancer Cells

  2025cites this paper
• B Cell Activating Factor Induces Drug Resistance in Hairy Cell Leukemia Variant

  2025influential citation
• Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions

  2025cites this paper
• Exploring the mechanisms by which common inhalational anesthetics influence malignant tumor metastasis: A data mining study based on comparative toxicogenomic databases.

  2025cites this paper
• Supramolecular Combination Chemotherapy: Directly Inducing Immunogenic Cell Death To Inhibit Tumor Metastasis via Host-Guest Interactions.

  2025cites this paper
• Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis.

  2025cites this paper
• Autocrine CXCL1-CXCR2 Signaling Mediates Leptomeningeal Resistance to Radiation Therapy

  2025cites this paper
• Phallus indusiatus Extracts Promoted MCF-7 Apoptosis Under TNFα-induced Tumor Microenvironment by Attenuating NF-kappaB and Akt Activation

  2025cites this paper
• A review concerning the breast cancer-related tumour microenvironment.

  2024cites this paper
• Neutrophils in cancer drug resistance: Roles and therapeutic opportunities.

  2024cites this paper
• Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer

  2024cites this paper
• Identification and validation of KIF20A for predicting prognosis and treatment outcomes in patients with breast cancer

  2024cites this paper
• Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression

  2024cites this paper
• Heterogeneity of tumor-associated neutrophils in hepatocellular carcinoma.

  2024cites this paper
• Phenotypic targeting using magnetic nanoparticles for rapid characterization of cellular proliferation regulators

  2024cites this paper
• Neutrophil extracellular traps modulate chemotherapy efficacy and its adverse side effects

  2024cites this paper
• Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy.

  2024cites this paper
• NETscape or NEThance: tailoring anti-cancer therapy.

  2024cites this paper
• The trogocytosis of neutrophils on initial transplanted tumor in mice

  2024cites this paper
• Neutrophil extracellular traps promote invasion and metastasis via NLRP3-mediated oral squamous cell carcinoma pyroptosis inhibition

  2024cites this paper
• Platelet-derived microparticles and their cargos: The past, present and future

  2024cites this paper
• H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis.

  2024cites this paper
• Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity

  2024cites this paper
• Key players of immunosuppression in epithelial malignancies: Tumor‐infiltrating myeloid cells and γδ T cells

  2024cites this paper
• S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models

  2024cites this paper
• Forces at play: exploring factors affecting the cancer metastasis

  2024cites this paper
• The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast

  2024cites this paper
• The Role of Alarmins in Breast Cancer

  2024cites this paper
• Crosstalk between cancer cells and macrophages promotes OSCC cell migration and invasion through a CXCL1/EGF positive feedback loop

  2024cites this paper
• Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance

  2024cites this paper
• Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade

  2024cites this paper
• S100A8 as a potential therapeutic target for cancer metastasis

  2024cites this paper
• Roles of Chemokine Axes in Breast Cancer.

  2024cites this paper
• Targeting SPP1-orchestrated neutrophil extracellular traps-dominant pre-metastatic niche reduced HCC lung metastasis

  2024cites this paper
• Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer

  2024cites this paper
• Cold-Inducible RNA Binding Protein Impedes Breast Tumor Growth in the PyMT Murine Model for Breast Cancer

  2024cites this paper
• Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance

  2024cites this paper
• Changes in serum CXCL13 levels are associated with outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

  2024cites this paper
• The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer

  2024cites this paper
• Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2

  2024cites this paper
• The role of surgical tissue injury and intraoperative sympathetic activation in postoperative immunosuppression after breast-conserving surgery versus mastectomy: a prospective observational study

  2024cites this paper
• Shuangshen Granules Suppress Myeloid-derived Suppressor Cell-mediated Lung Premetastatic Niche Development by Targeting Sphingosine-1-Phosphate Receptor-1/Signal Transducer, Activator of Transcription 3 Signaling

  2024cites this paper
• Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer

  2024cites this paper
• Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment

  2024cites this paper
• Exploring the evolution of T cell function and diversity across different stages of non-small cell lung cancer.

  2024cites this paper
• Potential Therapeutic Targets in Myeloid Cell Therapy for Overcoming Chemoresistance and Immune Suppression in Gastrointestinal Tumors.

  2024cites this paper
• Multifaceted roles of neutrophils in tumor microenvironment.

  2024cites this paper
• Immunomodulation by endothelial cells: prospects for cancer therapy.

  2024cites this paper
• Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis

  2024cites this paper
• Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation

  2024cites this paper
• Neutrophils in cancer: from biology to therapy

  2024cites this paper
• ACSL6-activated IL-18R1–NF-κB promotes IL-18–mediated tumor immune evasion and tumor progression

  2024cites this paper